CGCC is delighted to welcome three new members to the CGCC family. Approved for membership at the recent CGCC board meeting on December 18th, 2025, these companies represent diverse industries, including legal, medical, and transportation equipment.
Learn more about CGCC’s newest member companies below:
1. Mohnark Pharmaceuticals Inc.
Mohnark Pharmaceutical is an Over-the-Counter drug manufacturer of topical creams and gels. The company specializes in the manufacturing, packaging, and distribution of its own branded OTC products, including pain relief gels, antifungal treatments, and specialty care creams. Every formula is Made in the USA and backed by strict quality standards. The company currently has 6 FDA registered products with 4 more in the pipeline and expects to enter the Rx market with their first ANDA acquisition in 1st QTR 2026.
Founded in 1985, Jiaquan IP Law is a leading Chinese intellectual property firm with more than 800 professionals across multiple offices. Jiaquan provides full-service IP solutions—including patents, trademarks, litigation, invalidation, customs seizures, and licensing—supported by strong technical expertise in electronics, biotech, chemical, industrial, and mechanical sectors.
Cadidar Transport Equipment Co. LTD was established in 2005 to provide sourcing services and support to the global rail sector. With its headquarters based in Beijing, Cadidar’s initial effort was focused in China as a certified sourcing channel for CRRC (China Railway Rolling Stock Corp) for various systems, components and materials. Beginning in the fall of 2014, Cadidar expanded its operations for future growth in the United States, linking Chinese and US suppliers as well as OEMs in the rail car market.
CGCC eagerly anticipates their active participation and future contributions to the broader U.S.-China business community.
CLICK HERE to learn more about how your company can become a CGCC member